Form 8-K - Current report:
SEC Accession No. 0000950170-25-078439
Filing Date
2025-05-28
Accepted
2025-05-28 17:23:43
Documents
10
Period of Report
2025-05-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K catx-20250528.htm   iXBRL 8-K 64544
  Complete submission text file 0000950170-25-078439.txt   174397

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20250528.xsd EX-101.SCH 25913
12 EXTRACTED XBRL INSTANCE DOCUMENT catx-20250528_htm.xml XML 4918
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33407 | Film No.: 25996609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)